Phenotypic Characterization of a Comprehensive Set of MAPK1/ERK2 Missense Mutants.

ABSTRACT: Tumor-specific genomic information has the potential to guide therapeutic strategies and revolutionize patient treatment. Currently, this approach is limited by an abundance of disease-associated mutants whose biological functions and impacts on therapeutic response are uncharacterized. To begin to address this limitation, we functionally characterized nearly all (99.84%) missense mutants of MAPK1/ERK2, an essential effector of oncogenic RAS and RAF. Using this approach, we discovered rare gain- and loss-of-function ERK2 mutants found in human tumors, revealing that, in the context of this assay, mutational frequency alone cannot identify all functionally impactful mutants. Gain-of-function ERK2 mutants induced variable responses to RAF-, MEK-, and ERK-directed therapies, providing a refer

SUBMITTER: Brenan L 

PROVIDER: S-EPMC5120861 | biostudies-literature | 2016 Oct

REPOSITORIES: biostudies-literature